• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DNA
Click for more information
6.90% 3.1¢

DONACO INTERNATIONAL LIMITED

Market Cap $38.29M  ! watchlist Created with Sketch. Add to my watchlist
Consumer Cyclical Resorts & Casinos

Donaco International Limited is an Australia-based company, which operates leisure and... Donaco International Limited is an Australia-based company, which operates leisure and hospitality businesses across the Asia Pacific region. The Company’s segments include Casino Operations-Vietnam, Casino Operations-Cambodia, and Corporate Operations. The Casino Operations-Vietnam segment is comprised of the Aristo International Hotel operating in Vietnam. These operations include hotel accommodation, and gaming and leisure facilities. The Casino Operations-Cambodia segment comprises the Star Vegas Resort and Club, operating in Cambodia. Its operations include hotel accommodation and gaming and leisure facilities. The Corporate Operations segment consists of development and implementation of corporate strategy, commercial negotiations, corporate finance, treasury, management accounting, corporate governance, and investor relations functions. Its Star Vegas Resort and Club is a casino resort in Poipet. The Aristo International Hotel is located on the border between China and Vietnam.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
DNA
Ann: FY24 Results Presentation 		16/09/24 15 3.9K
16/09/24 Last post  Flognoggle Comments Created with Sketch.  15  Views Created with Sketch.  3.9K 
DNA
Ann: FY24 Results Commentary 		30/08/24 0 133
30/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  133 
DNA
Ann: Preliminary Final Report 		30/08/24 0 144
30/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  144 
DNA
Ann: Quarterly Activities and Cashflow Reports 		28/08/24 32 8.2K
28/08/24 Last post  Dave12 Comments Created with Sketch.  32  Views Created with Sketch.  8.2K 
DNA
Ann: 1H FY24 Investor Presentation 		24/07/24 37 16K
24/07/24 Last post  61212305 Comments Created with Sketch.  37  Views Created with Sketch.  16K 
DNA
PE Ratio of less than 2. Is this casino stock worth a gamble? 		27/04/24 5 2.9K
27/04/24 Last post  Miroboti Comments Created with Sketch.  5  Views Created with Sketch.  2.9K 
DNA
Ann: Quarterly Activities and Cashflow Reports 		26/04/24 11 3.4K
26/04/24 Last post  61212305 Comments Created with Sketch.  11  Views Created with Sketch.  3.4K 
DNA
News: DNA Donaco International Announces Qtrly Group Net Revenue Of A$12.66 Mln 		24/04/24 0 258
24/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  258 

See All Discussions arrow Created with Sketch.

Timeline

FY24 Results Presentation
30 Aug 08:13
 
FY24 Results Commentary
30 Aug 08:12
 
Preliminary Final Report
30 Aug 08:09
 
Quarterly Activities and Cashflow Reports
26 Jul 17:55
 
Quarterly Activities and Cashflow Reports
24 Apr 15:22
 
1H FY24 Investor Presentation
28 Feb 15:04
 
View More arrow Created with Sketch.

Featured News

NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
NEWS Positive results highlight gold and lithium potential at Shoobridge
right-arrow Created with Sketch.
NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
(20min delay)
Last
3.1¢ 		Change
0.002(6.90%) 		Mkt cap ! $38.29M
Open High Low Value Volume
3.0¢ 3.1¢ 3.0¢ $2.117K 70K

Buyers (Bids)

No. Vol. Price($)
1 5633 2.9¢
 

Sellers (Offers)

Price($) Vol. No.
3.1¢ 153443 4
View Market Depth
Last trade - 13.34pm 20/09/2024 (20 minute delay) ?
DNA (ASX) Chart

Top Stories

Harvey Norman hit with a second class action – and shareholders, once again, don't care

Harvey Norman (ASX:HVN) has confirmed it's been hit by a second class action this week over allegedly dodgy warranty cover – and the stock is up +1.23 at 11.15am Sydney time.
ASX Market Open: Aussie stocks follow US surge after Fed rate cut decision | September 20, 2024 Australia's stock market is set to open higher today, following record performances on Wall Street, following the Federal Reserve's rate cut
Develop Global appoints GR to get Woodlawn copper-zinc plant online mid-2025 Develop shares jumped just over 4% in lunchtime trades on Friday as the company sees mid-2025 Woodlawn start.
Sandfire's latest drill run extends known polymetal mineralisation at the Sesmarias Prospect Sandfire Limited (ASX:SFR) has posted evidence of extended mineralisation at its Portugese Sesmarias Prospect.
Westar wraps up field campaign at Mindoolah after divesting non-core assets ahead of 2025 Westar Resources (ASX:WSR) has wrapped up a field campaign on-site its Mindoolah Mining Centre project in WA.

Featured News

EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Positive results highlight gold and lithium potential at Shoobridge
right-arrow Created with Sketch.
NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.